Safety and Efficacy of a Drug Delivery System in Glaucoma

NCT01016691 Phase 2 COMPLETED Results posted

Evaluation of the ocular safety and efficacy of a drug delivery system in open-angle glaucoma or ocular hypertension.

Details

Lead sponsor	Vistakon Pharmaceuticals
Phase	Phase 2
Status	COMPLETED
Enrolment	47
Start date	2009-10

Conditions

• Open-angle Glaucoma
• Ocular Hypertension

Interventions

• High Dose Drug Device
• Low Dose Drug Device
• Placebo Device
• bimatoprost 0.03%

Primary outcomes

• Mean Change in Intraocular Pressure at Day 1 — Baseline to Day 1

Countries

United States